Cycn investor relations
WebInstitutional investors control 48.45% of the outstanding shares in CYCN. This represents a greater percentage of ownership than at almost any other company in the … WebApr 6, 2024 · Of the 23 institutional investors that sold Cyclerion Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Vanguard Group Inc. ($0.47M), State Street Corp ($0.32M), Renaissance Technologies LLC ($0.32M), Northern Trust Corp ($0.19M), FMR LLC ($0.13M), New …
Cycn investor relations
Did you know?
WebJan 12, 2024 · Review Cyclerion Therapeutics Inc Ordinary Shares (CYCN:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions. WebOct 30, 2024 · Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announces positive dude iligence 01/09/20 3:36 PM CYCN $3.05 chart huge potential How Big HUGE! Actualfactual 01/08/20 2:21 PM Broke...
WebSummary Financials Analysis Earnings Investors. . . Key Ratios Income Statement Balance Sheet Cash Flow. All. Per Share Values. Growth Rates. ... CYCN 2024. CYCN 3-Yr Avg. Biotech. 1-Yr Avg. Asset ... WebDec 3, 2024 · Cyclerion Therapeutics, Inc. (NASDAQ: CYCN) was in 6 hedge funds' portfolios at the end of the third quarter of 2024. The all time high for this statistics is 17. Our calculations also showed...
WebApr 3, 2024 · Cyclerion Investor Relations Phone: 857-327-8778 Email: [email protected] Rejuvenate Your Portfolio with Options! Bounce back from 2024 with Chris Capre's expert options trade ideas for an... WebMar 10, 2024 · We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold …
WebMay 9, 2024 · Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) shareholders (or potential shareholders) will be happy to see that the CEO & Director, Peter Hecht, recently bought a whopping US$1.7m worth of stock, at ...
WebMar 2, 2024 · Learn about the executive team and board of directors at Cyclerion Therapeutics Inc Ordinary Shares (CYCN:XNAS) and review their bios and … cryptyde priceWebNov 22, 2024 · The Investor Relations website contains information about Cyclerion Therapeutics, Inc.'s business for stockholders, potential investors, and financial … CNS is a high-reward space with large and growing unmet need due to an aging … Leveraging a Critical Pathway. Cyclerion was founded with the goal of unlocking … Culture & Careers. We have an exceptional team at Cyclerion with a vibrant and … Investor Resources; Culture & Careers; Our Commitment. We are committed to … crypty crawlerWebHere are some key insights as we drill into the specifics of these quality attributes. CYCN has a Quality Grade of C, ranking ahead of 48.21% of graded US stocks. CYCN's asset turnover comes in at 0.034 -- ranking 346th of 682 Pharmaceutical Products stocks. The table below shows CYCN's key quality metrics over time. cryptyde inc. stockWebCyclerion Therapeutics Inc (NASDAQ:CYCN) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position … dutch oven cinnamon rolls campingWebThe latest price target for . Cyclerion Therapeutics (NASDAQ: CYCN) was reported by Truist Securities on October 20, 2024.The analyst firm set a price target for $14.00 expecting CYCN to rise to ... cryptyde valuationWebJun 7, 2024 · Cyclerion Therapeutics Inc (CYCN) stock is up 6.54% while the S&P 500 is down -0.32% as of 11:55 AM on Monday, Jun 7. CYCN is higher by $0.21 from the previous closing price of $3.19 on volume of 2,783,678 shares. Over the past year the S&P 500 is higher by 30.44% while CYCN is down -34.99%. cryptyde earningsWebCYCN Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 55 Institutional Holders 21,001,047 Total Shares Held Back to CYCN Overview … dutch oven cinnamon raisin bread recipes easy